Michael McDermott - Feb 25, 2023 Form 4 Insider Report for PFIZER INC (PFE)

Signature
Susan E. Grant, by power of atty., for Michael McDermott
Stock symbol
PFE
Transactions as of
Feb 25, 2023
Transactions value $
-$193,526
Form type
4
Date filed
2/28/2023, 04:52 PM
Previous filing
Feb 24, 2023
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $325K +14.2K +17.96% $22.89 93.1K Feb 25, 2023 Direct F1
transaction PFE Common Stock Tax liability -$119K -2.84K -3.05% $41.75 90.3K Feb 25, 2023 Direct F2, F3
transaction PFE Common Stock Tax liability -$274K -6.31K -6.99% $43.44 84K Feb 25, 2023 Direct F4, F5
transaction PFE Common Stock Tax liability -$126K -3.08K -3.67% $40.78 80.9K Feb 27, 2023 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -14.2K -100% $0.00* 0 Feb 25, 2023 Common Stock 14.2K $22.89 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 Price is the closing price of Pfizer common stock on February 24, 2023.
F4 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F6 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F7 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.